111 related articles for article (PubMed ID: 27833513)
1. Plasma and Urinary Type IV Collagen Levels for Early Detection of Nephropathy in Type 2 Diabetes Mellitus Patients.
Mahendran KB; Bhaskar MV; Santha K; Inmozhi R; Perumal KK
Int J Health Sci (Qassim); 2016 Oct; 10(4):492-498. PubMed ID: 27833513
[TBL] [Abstract][Full Text] [Related]
2. Follow-up study on urinary type IV collagen in patients with early stage diabetic nephropathy.
Iijima T; Suzuki S; Sekizuka K; Hishiki T; Yagame M; Jinde K; Saotome N; Suzuki D; Sakai H; Tomino Y
J Clin Lab Anal; 1998; 12(6):378-82. PubMed ID: 9850190
[TBL] [Abstract][Full Text] [Related]
3. Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy.
Tashiro K; Koyanagi I; Ohara I; Ito T; Saitoh A; Horikoshi S; Tomino Y
J Clin Lab Anal; 2004; 18(3):206-10. PubMed ID: 15103687
[TBL] [Abstract][Full Text] [Related]
4. Urinary type IV collagen levels in diabetes mellitus.
Sthaneshwar P; Chan SP
Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
[TBL] [Abstract][Full Text] [Related]
5. Serum type IV collagen in diabetic patients at risk for nephropathy.
Cohen MP; Shearman CW; Lautenslager GT
Diabetes Care; 2001 Aug; 24(8):1324-7. PubMed ID: 11473064
[TBL] [Abstract][Full Text] [Related]
6. [Can urine albumin/creatinine ratio replace 24 hours urinary albumin?].
Liu R; Zhu H; Yang JH; Gao ZA; Yuan XX; Li XC; Wang JY; Chang BC
Zhonghua Nei Ke Za Zhi; 2019 May; 58(5):377-381. PubMed ID: 31060147
[No Abstract] [Full Text] [Related]
7. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
Banu N; Hara H; Okamura M; Egusa G; Yamakido M
Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
[TBL] [Abstract][Full Text] [Related]
8. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
[TBL] [Abstract][Full Text] [Related]
9. The Value of Serum Prolidase Activity in Progression of Microalbuminuria in Patients With Type 2 Diabetes Mellitus.
Sabuncu T; Boduroglu O; Eren MA; Torun AN; Aksoy N
J Clin Lab Anal; 2016 Sep; 30(5):557-62. PubMed ID: 26666214
[TBL] [Abstract][Full Text] [Related]
10. Urinary type IV collagen: a specific indicator of incipient diabetic nephropathy.
Tan Y; Yang Y; Zhang Z; Zhang X; Zhang Z; Liu Y
Chin Med J (Engl); 2002 Mar; 115(3):389-94. PubMed ID: 11940372
[TBL] [Abstract][Full Text] [Related]
11. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.
Banu N; Hara H; Egusa G; Yamakido M
Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Microalbuminuria among Rural North Indian Population with Diabetes Mellitus and its Correlation with Glycosylated Haemoglobin and Smoking.
Aggarwal J; Kumar M
J Clin Diagn Res; 2014 Jul; 8(7):CC11-3. PubMed ID: 25177561
[TBL] [Abstract][Full Text] [Related]
13. A new enzyme-linked immunosorbent assay for urine and serum concentrations of the carboxyterminal domain (NCl) of collagen. IV. Application in type I (insulin-dependent) diabetes.
Torffvit O; Agardh CD; Cederholm B; Wieslander J
Scand J Clin Lab Invest; 1989 Sep; 49(5):431-9. PubMed ID: 2595239
[TBL] [Abstract][Full Text] [Related]
14. Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
Nicola W; Sidhom G; El Khyat Z; Ibrahim S; Salah A; El Sayed A
Endocr J; 2001 Feb; 48(1):25-31. PubMed ID: 11403100
[TBL] [Abstract][Full Text] [Related]
15. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix proteins as early markers in diabetic nephropathy.
Jäckle-Meyer I; Szukics B; Neubauer K; Metze V; Petzoldt R; Stolte H
Eur J Clin Chem Clin Biochem; 1995 Apr; 33(4):211-9. PubMed ID: 7626693
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of type IV collagen as a specific indicator of the progression of diabetic nephropathy.
Watanabe H; Sanada H; Shigetomi S; Katoh T; Watanabe T
Nephron; 2000 Sep; 86(1):27-35. PubMed ID: 10971150
[TBL] [Abstract][Full Text] [Related]
18. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
[TBL] [Abstract][Full Text] [Related]
19. Plasma endoglin in Type2 diabetic patients with nephropathy.
Doghish AS; Bassyouni AA; Mahfouz MH; Abd El-Aziz HG; Zakaria RY
Diabetes Metab Syndr; 2019; 13(1):764-768. PubMed ID: 30641803
[TBL] [Abstract][Full Text] [Related]
20. Microalbuminuria and Its Risk Factors in Type 2 Diabetic Patients.
Thakur SK; Dhakal SP; Parajuli S; Sah AK; Nepal SP; Paudel BD
J Nepal Health Res Counc; 2019 Apr; 17(1):61-65. PubMed ID: 31110390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
